UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004040
Receipt number R000004868
Scientific Title Prospective cohort study to evaluate the efficacy and safety of endoscopic submucosal dissection for colorectal tumor
Date of disclosure of the study information 2010/08/14
Last modified on 2024/03/21 16:16:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective cohort study to evaluate the efficacy and safety of endoscopic submucosal dissection for colorectal tumor

Acronym

Prospective cohort study to evaluate the efficacy and safety of ESD for colorectal tumor

Scientific Title

Prospective cohort study to evaluate the efficacy and safety of endoscopic submucosal dissection for colorectal tumor

Scientific Title:Acronym

Prospective cohort study to evaluate the efficacy and safety of ESD for colorectal tumor

Region

Japan


Condition

Condition

colorectal tumor

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the efficacy and safety of ESD for colorectal tumor

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of complete en bloc resection and complication in colorectal ESD

Key secondary outcomes

Prevalence of local/residual recurrence after ESD


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Colorectal ESD cases

Early colorectal cancer (larger than 20 mm in diameter) for which endoscopic treatment is indicative but for which en bloc resection by snare EMR would be difficult.

Adenoma with non-lifting sign (+) after injection during EMR procedures.

Local residual tumor after EMR (larger than 10 mm in diameter) for which en bloc resection by snare EMR would be difficult.

Key exclusion criteria

Excluding the sentences above

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michio Kaminishi

Organization

Japan Gastroenterological Endoscopy Society (JGES)

Division name

President

Zip code


Address

3-22 Kanda Ogawamachi, Chiyoda-ku, Tokyo, Japan

TEL

03-3291-4111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideki Ishikawa

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Molecular-Targeting Cancer Prevention

Zip code


Address

3-1-2F Kyomachibori Nishi-ku 2-chome Osaka 550-0003, Japan

TEL

06-6445-5585

Homepage URL


Email

cancer@gol.com


Sponsor or person

Institute

Japan Gastroenterological Endoscopy Society (JGES)

Institute

Department

Personal name



Funding Source

Organization

Japan Gastroenterological Endoscopy Society (JGES)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 14 Day


Related information

URL releasing protocol

https://jpn01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.jstage.jst.go.jp%2Farticle%2Fg

Publication of results

Unpublished


Result

URL related to results and publications

https://jpn01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.jstage.jst.go.jp%2Farticle%2Fg

Number of participants that the trial has enrolled

1564

Results

ESD was completed without interception in 1544 (98.7%) patients. Intraoperative bleeding, postoperative bleeding, intraoperative perforation, postoperative perforation, penetration, and peritonitis occurred in 19(1.2%), 43 (2.8%), 47 (3.0%), 6 (0.4%), 19 (1.2%), and 8 (0.5%) patients, respectively. Emergency surgical rescue was necessary in 8 (0.5%) patients(4 for intraoperative perforation, 4 for postoperative perforation).

Results date posted

2024 Year 03 Month 21 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2015 Year 06 Month 01 Day

Baseline Characteristics

This nationwide registry aimed to accumulate more than 1000 consecutive patients with colorectal ESD throughout Japan from August 2010 to January 2012 for data analysis with sufficient power. Before starting this registry, the organizing committee for investigation of colorectal ESD in JGES was formulated.

Participant flow

This nationwide registry collected 1564 patients with colorectal ESD at 69 hospitals in Japan from August 2010 to January 2012. Clnicopathological characteristics are shown in Table 1. Mean tumor size was 32.5 mm (range, 4-100 mm) and 984 (62.9%) lesions were finally diagnosed as carcinoma after ESD.

Adverse events

Intraoperative bleeding, postoperative bleeding, intraoperative perforation, postoperative perforation, penetration, and peritonitis occurred in 19 (1.2%), 43 (2.8%), 47 (3.0%), 6 (0.4%), 19 (1.2%), and 8 (0.5%) patients, respectively. Emergency surgical rescue was necessary in 8 (0.5%) patients (4 for intraoperative perforation, 4 for postoperative perforation). Transfusion was performed in one patient (0.06%) due to postoperative bleeding. Follow up in one year revealed a rate of local recurrence was
0.90%(11/1217).

Outcome measures

Treatment outcomes, especially rates of en bloc resection, en bloc plus R0 (tumor-free margins) resection and ESD related complications were investigated.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 06 Month 29 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cohort study


Management information

Registered date

2010 Year 08 Month 14 Day

Last modified on

2024 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004868


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name